Revelol-CH 25mg/6.25mg Tablet
Marketer
Ipca Laboratories Ltd
Salt Composition
Metoprolol Succinate (25mg) + Chlorthalidone (6.25mg)
Overview Revelol-CH 25mg/6.25mg Tablet
Cardio-Hypertensive 25mg/6.25mg tablets are prescribed for managing hypertension (high blood pressure). This medication is indicated when a single antihypertensive agent proves insufficient. It contributes to lowering the risk of future cardiovascular events, including stroke and myocardial infarction. Prompt treatment improves survival rates following a heart attack. Cardio-Hypertensive 25mg/6.25mg tablets should be taken once daily, preferably in the morning, with or without food, to minimize nocturnal urination. Continue this medication as directed by your physician; discontinuation, even with improved well-being, is inadvisable as hypertension often presents asymptomatically. Ceasing treatment may worsen the condition. Lifestyle modifications such as regular physical activity, weight management, and a balanced diet further support blood pressure control. Adhere strictly to your doctor's instructions. Common adverse effects include nausea, constipation, diarrhea, and fatigue. Report any persistent, worsening, or bothersome side effects to your doctor. Increased fluid intake may alleviate symptoms like muscle weakness, dry mouth, and thirst. Transient dizziness or headaches due to lowered blood pressure are usually self-limiting. Prior to commencing treatment, inform your doctor of any existing liver or kidney disease. Pregnant or lactating individuals should seek medical counsel before use. Disclose all current medications, especially those for hypertension or heart conditions. Regular monitoring of blood pressure, renal function, blood glucose, and electrolytes (potassium, magnesium) is crucial to ensure therapeutic efficacy.
Uses of Revelol-CH 25mg/6.25mg Tablet
Elevated arterial blood pressure
Major Benefits of Revelol-CH 25mg/6.25mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 25mg/6.25mg Revelol-CH tablet whole; avoid chewing, crushing, or fracturing it. Consumption may coincide with meals or be taken independently, though consistent timing is recommended.
Common Side effects of Revelol-CH 25mg/6.25mg Tablet:
- Nausea
- Constipation
- Diarrhea
- Fatigue
- Headache
- Dizziness
- Slow heart rate
- Increased blood uric acid
- Decreased potassium level in blood
- Glucose intolerance
- Altered blood lipid level
- Cold extremities
- Decreased magnesium level in blood
- Increased calcium level in blood
How to use Revelol-CH 25mg/6.25mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Revelol-CH 25mg/6.25mg tablets can be consumed with or without food, although consistent timing is recommended.
How Revelol-CH 25mg/6.25mg Tablet works:
Each Revelol-CH 25mg/6.25mg tablet unites Metoprolol Succinate and Chlorthalidone, two agents that decrease blood pressure. Metoprolol Succinate, a beta-blocker, acts directly on the heart, slowing its rhythm and enhancing its pumping efficiency. Chlorthalidone, a diuretic, reduces blood pressure by eliminating excess fluid and electrolytes, while concurrently promoting vasodilation and improved circulation.
SAFETY ADVICE
AlcoholUNSAFE
Combining Revelol-CH 25mg/6.25mg tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The use of Revelol-CH 25mg/6.25mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescription. Seek medical advice.
Breast feedingSAFE IF PRESCRIBED
Use of Revelol-CH 25mg/6.25mg tablets while breastfeeding is likely safe. Available human data indicates minimal risk to the infant.
DrivingUNSAFE
Taking Revelol-CH 25mg/6.25mg tablets can cause drowsiness, blurred vision, and dizziness. Refrain from driving if you experience these effects.
KidneyCAUTION
Patients with severe kidney impairment should use Revelol-CH 25mg/6.25mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised; the use of Revelol-CH 25mg/6.25mg tablets is generally discouraged in such cases.
LiverCAUTION
Patients with hepatic impairment should use 25mg/6.25mg Revelol-CH tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. The use of 25mg/6.25mg Revelol-CH tablets is contraindicated in individuals with severe liver disease.
What if you forget to take Revelol-CH 25mg/6.25mg Tablet :
Should you forget a Revelol-CH 25mg/6.25mg Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Revelol-CH 25mg/6.25mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | HEART |






